HIV News and Research

RSS

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

CEL-SCI Corporation announced that its longstanding collaboration with Northeast Ohio Medical University has produced a new investigational breast cancer vaccine which prevents and treats a HER-2/neu expressing breast cancer tumor in a mouse model of the disease.

31 Jan 2013

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).

31 Jan 2013

TB test offers rapid detection of TB and drug-resistant strains according to new study

A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® MTB/RIF test published in The Cochrane Library say their study can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem.

31 Jan 2013

C. albicans capable of sexual reproduction

Like many fungi and one-celled organisms, Candida albicans, a normally harmless microbe that can turn deadly, has long been thought to reproduce without sexual mating. But a new study by Professor Judith Berman and colleagues at the University of Minnesota and Tel Aviv University shows that C. albicans is capable of sexual reproduction.

31 Jan 2013

Global Fund Observer reports on new funding model progress

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.

31 Jan 2013

Government mistrust and conspiracy fears deter older adults from getting tested for HIV

One out of every four people living with HIV/AIDS is 50 or older, yet these older individuals are far more likely to be diagnosed when they are already in the later stages of infection. Such late diagnoses put their health, and the health of others, at greater risk than would have been the case with earlier detection.

31 Jan 2013

International community must continue to fund efforts to stop spread of infectious diseases

Writing in the Huffington Post's "The Big Push" blog, Dirk Niebel, Germany's federal minister of economic cooperation and development, discusses "why Germany announced last week that it is committing one billion euros over five years to the Global Fund."

31 Jan 2013

Vaccine confidence: an interview with Dr Heidi Larson

Here at the London School of Hygiene and Tropical Medicine we are running a project called the Vaccine Confidence Project and we have a global surveillance monitoring information around the world on media, social media, all sorts of information, reports from governments, UN, other sources, looking for any what we call “signals” of public distrust or concerns that come up.

30 Jan 2013

HIV/AIDS Legal Assessment Tool aims to tackle HIV-related discrimination

Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Jennifer James, founder of Mom Bloggers for Social Good, examines the HIV/AIDS Legal Assessment Tool created by the American Bar Association Rule of Law Initiative.

30 Jan 2013

Blog examines next steps should a therapeutic AIDS vaccine be developed

In a post in the "Tomorrow Global" blog, Danielle Parsons, an HIV/AIDS specialist, highlights a number of advances made in the search for an AIDS vaccine, writing, "All of this work is promising, and it's starting to feel like we're back on track for a successful therapeutic vaccine in the next decade."

30 Jan 2013

U.S. Supreme Court should end 'counterproductive' federal anti-prostitution pledge

In the Huffington Post's "Politics" blog, journalist and author John-Manuel Andriote notes the U.S. Supreme Court this month agreed to hear a case challenging the federal anti-prostitution pledge, which requires groups that receive federal funding for overseas HIV/AIDS programs to sign a pledge denouncing prostitution and sex trafficking as a condition for receiving funding, and describes the history of the policy.

30 Jan 2013

HIV-positive patients have higher incidence of non-melanoma skin cancers

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.

30 Jan 2013

New DNA-delivering film holds promise for improving effectiveness of vaccines

Vaccines usually consist of inactivated viruses that prompt the immune system to remember the invader and launch a strong defense if it later encounters the real thing. However, this approach can be too risky with certain viruses, including HIV.

29 Jan 2013

Germany commits to providing 1B euros to Global Fund through 2016

"Germany will give one billion euros $1.3 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the country's minister for economic cooperation and development Dirk Niebel said Thursday" during the World Economic Forum in Davos, Switzerland, CNN reports.

28 Jan 2013

Urging U.N. to collect, report data on aging population affected by HIV

"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."

28 Jan 2013

Blogs examine leadership changes that may affect global health as Obama begins second term

"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.

28 Jan 2013

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.

28 Jan 2013

Targeting key HIV protein could stop HIV infection from progressing to AIDS

Researchers at the University of Pittsburgh School of Medicine may have found an "Achilles heel" in a key HIV protein. In findings published online today in Chemistry and Biology, they showed that targeting this vulnerable spot could stop the virus from replicating, potentially thwarting HIV infection from progressing to full-blown AIDS.

25 Jan 2013

New handheld device performs rapid HIV tests

Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has taken his innovative lab-on-a-chip and developed a way to not only check a patient's HIV status anywhere in the world with just a finger prick, but also synchronize the results automatically and instantaneously with central health-care records-10 times faster, the researchers say, than the benchtop ELISA, a broadly used diagnostic technique.

25 Jan 2013

Sex rated as highly arousing and pleasurable whether or not condoms and lubricants are used

A new study published in The Journal of Sexual Medicine reveals that within a nationally representative study of American men and women, sex was rated as highly arousing and pleasurable whether or not condoms and/or lubricants were used. Condoms and lubricants are commonly used by both women and men when they have sex.

23 Jan 2013

HIV News and Research

Northeast Ohio Medical University, CEL-SCI produce new investigational breast cancer vaccine

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

TB test offers rapid detection of TB and drug-resistant strains according to new study

C. albicans capable of sexual reproduction

Global Fund Observer reports on new funding model progress

Government mistrust and conspiracy fears deter older adults from getting tested for HIV

International community must continue to fund efforts to stop spread of infectious diseases

Vaccine confidence: an interview with Dr Heidi Larson

HIV/AIDS Legal Assessment Tool aims to tackle HIV-related discrimination

Blog examines next steps should a therapeutic AIDS vaccine be developed

U.S. Supreme Court should end 'counterproductive' federal anti-prostitution pledge

HIV-positive patients have higher incidence of non-melanoma skin cancers

New DNA-delivering film holds promise for improving effectiveness of vaccines

Germany commits to providing 1B euros to Global Fund through 2016

Urging U.N. to collect, report data on aging population affected by HIV

Blogs examine leadership changes that may affect global health as Obama begins second term

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Targeting key HIV protein could stop HIV infection from progressing to AIDS

New handheld device performs rapid HIV tests

Sex rated as highly arousing and pleasurable whether or not condoms and lubricants are used

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News